Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Other Non-Current Assets (2020 - 2025)

Bio Essence has reported Other Non-Current Assets over the past 6 years, most recently at $50000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 14960.24% year-over-year to $50000.0; the TTM value through Dec 2025 reached $50000.0, up 14960.24%, while the annual FY2025 figure was $50000.0, 14960.24% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $50000.0 at Bio Essence, roughly flat from $50000.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $1.5 million in Q4 2023 and troughed at $332.0 in Q4 2024.
  • A 5-year average of $253919.6 and a median of $50000.0 in 2025 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: tumbled 99.98% in 2024 and later surged 14960.24% in 2025.
  • Year by year, Other Non-Current Assets stood at $41841.0 in 2021, then soared by 2059.49% to $903552.0 in 2022, then skyrocketed by 64.32% to $1.5 million in 2023, then tumbled by 99.98% to $332.0 in 2024, then surged by 14960.24% to $50000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for BIOE at $50000.0 in Q4 2025, $50000.0 in Q3 2025, and $50000.0 in Q2 2025.